COPD clinical trials in Massachusetts
25 studies for COPD are looking for participants at sites in Massachusetts.
Cities in Massachusetts
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Brigham and Women's Hospital, Boston
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Sep 25, 2026 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Brigham & Women's Hospital- Site Number : 8400148, Boston
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 22, 2026 · NCT07190209A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Brigham & Women's Hospital- Site Number : 8400014, Boston
RecruitingPhase 4
Ages 40 to 85 · All sexes · Updated Sep 22, 2026 · NCT07053423An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Beth Israel Deaconess Medical Center, Boston
Recruiting
Ages 40 to 80 · All sexes · Updated Sep 17, 2026 · NCT06035120Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Lucida Clinical Trials- Site Number : 8400101, New Bedford
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 15, 2026 · NCT07190222A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, North Dartmouth
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Sep 15, 2026 · NCT07646587A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Burlington
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 9, 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, North Dartmouth
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Exordia Medical Research Inc., Fall River
- Infinity Medical Research, North Dartmouth
RecruitingPhase 2/3
Ages 35 to 80 · All sexes · Updated Aug 31, 2026 · NCT07363694Inter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction
- Beth Israel Deaconess Medical Center, Boston
Recruiting
Ages 40 to 75 · All sexes · Updated Aug 28, 2026 · NCT05257681A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Boston
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Aug 26, 2026 · NCT06283966STRIVE Post-Market Registry Study
- Beth Israel Decaconess, Boston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT04302272Multi-Center Clean Air Randomized Controlled Trial in COPD
- Beth Israel Deaconess Medical Center, Boston
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Jul 31, 2026 · NCT06376994Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling
- Baystate Health, Springfield
Recruiting
Ages 40 and older · All sexes · Updated Jun 5, 2026 · NCT05399056A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
- Beth Israel Deaconess Medical Center, Boston
Recruiting
Ages 22 and older · All sexes · Updated Jun 3, 2026 · NCT07119229Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
RecruitingPhase 2
Ages 35 to 89 · All sexes · Updated May 15, 2026 · NCT05937854Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Beth Israel Deaconess Medical Center, Boston
Recruiting
Ages 40 to 84 · All sexes · Updated Apr 24, 2026 · NCT06891755Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema
- Beth Israel Deaconess Medical Center, Boston
Recruiting
Ages 40 to 75 · All sexes · Updated Apr 13, 2026 · NCT04801108Home Hospital for Suddenly Ill Adults
- Brigham and Women's Hospital, Boston
- Brigham and Women's Faulkner Hospital, Boston
Recruiting
Ages 18 and older · All sexes · Updated Mar 17, 2026 · NCT03524222The Effect of a Technology-Mediated Integrated Walking and Tai Chi Intervention on Physical Function in Veterans With COPD and Chronic Musculoskeletal Pain
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Recruiting
Ages 40 to 100 · All sexes · Updated Jan 22, 2026 · NCT05701982Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
- University of Massachusetts Chan Medical School, Worcester
Recruiting
Ages 18 and older · All sexes · Updated Nov 26, 2025 · NCT07072039Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
- Brigham and Women's Hospital, Boston
RecruitingObservational study
All ages · All sexes · Updated Oct 24, 2025 · NCT01177618Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Cape Cod Hospital, Hyannis
RecruitingObservational study
Ages 50 and older · All sexes · Updated Aug 5, 2025 · NCT06122077Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
- VA Boston, Boston
- BIDMC, Boston
Recruiting
Ages 40 and older · All sexes · Updated May 28, 2025 · NCT05934565myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Tufts Medical Center, Boston
- Lahey Hospital and Medical Center, Burlington
Recruiting
Ages 30 and older · All sexes · Updated Feb 6, 2025 · NCT05204888From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.